INS and type 2 diabetes mellitus: After adjustment for fibrinogen (F = 9.0, df = 1, P = 0.003), HbA1c (F = 3.2, df = 1, P = 0.08), T2DM duration (F = 6.7, df = 1, P = 0.01) and insulin therapy (F = 2.2, df = 1, P = 0.14), glucose concentration significantly influenced peak thrombin generation (F = 13.5, df = 2, P < 0.0001).